NL7316749A - - Google Patents

Info

Publication number
NL7316749A
NL7316749A NL7316749A NL7316749A NL7316749A NL 7316749 A NL7316749 A NL 7316749A NL 7316749 A NL7316749 A NL 7316749A NL 7316749 A NL7316749 A NL 7316749A NL 7316749 A NL7316749 A NL 7316749A
Authority
NL
Netherlands
Application number
NL7316749A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12360272A external-priority patent/JPS5549594B2/ja
Priority claimed from JP11454273A external-priority patent/JPS5549596B2/ja
Application filed filed Critical
Publication of NL7316749A publication Critical patent/NL7316749A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7316749A 1972-12-08 1973-12-06 NL7316749A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12360272A JPS5549594B2 (sv) 1972-12-08 1972-12-08
JP11454273A JPS5549596B2 (sv) 1973-10-11 1973-10-11

Publications (1)

Publication Number Publication Date
NL7316749A true NL7316749A (sv) 1974-06-11

Family

ID=26453287

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7316749A NL7316749A (sv) 1972-12-08 1973-12-06

Country Status (10)

Country Link
US (1) US3936439A (sv)
CA (1) CA1012534A (sv)
CH (1) CH587864A5 (sv)
DE (1) DE2359536C2 (sv)
DK (1) DK134490B (sv)
FR (1) FR2209567B1 (sv)
GB (1) GB1418120A (sv)
HU (1) HU167859B (sv)
NL (1) NL7316749A (sv)
SE (1) SE400295B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5461194A (en) * 1977-10-21 1979-05-17 Takeda Chem Ind Ltd Preparation of n22substituted 2*66diaminonebularin
JPS5461195A (en) * 1977-10-21 1979-05-17 Takeda Chem Ind Ltd N2-substituted phenyl-2,6-diaminonebularin
AU5118979A (en) * 1978-10-16 1980-04-24 Takeda Chemical Industries Ltd. 2,6-diaminoebularines
JPS55130998A (en) * 1979-04-02 1980-10-11 Takeda Chem Ind Ltd N2-substituted 2,6-diaminonebularin
JPS56152437U (sv) * 1980-04-14 1981-11-14
US4663446A (en) * 1983-06-27 1987-05-05 Trustees Of The Univ. Of Massachusetts N2 (phenyl substituted) deoxy guanosine containing compounds
FR2575751B1 (fr) * 1985-01-08 1987-04-03 Pasteur Institut Nouveaux nucleosides de derives de l'adenosine, leur preparation et leurs applications biologiques
US5063233A (en) * 1986-11-14 1991-11-05 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists
US4954504A (en) * 1986-11-14 1990-09-04 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
US4968697A (en) * 1987-02-04 1990-11-06 Ciba-Geigy Corporation 2-substituted adenosine 5'-carboxamides as antihypertensive agents
PE20030008A1 (es) * 2001-06-19 2003-01-22 Bristol Myers Squibb Co Inhibidores duales de pde 7 y pde 4
GB0228723D0 (en) * 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305150D0 (en) 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Use of therapeutic compounds
GB0305149D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
GB0305153D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Identification of therapeutic compounds
BRPI0508488A (pt) * 2004-03-05 2007-07-31 Cambridge Biotechnology Ltd compostos terapêuticos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL299755A (sv) * 1959-06-03
US3404144A (en) * 1965-12-23 1968-10-01 Research Corp 1-beta-d-arabinofuranosyl-5-fluorocytosine compounds
US3431252A (en) * 1966-04-01 1969-03-04 Merck & Co Inc 5,5-dialkyl-d-ribofuranosyl purine compounds and intermediates
DE1670265A1 (de) * 1967-08-25 1971-01-28 Boehringer Mannheim Gmbh 2-Amino-Adenosinderivate und Verfahren zu deren Herstellung
US3752805A (en) * 1969-06-05 1973-08-14 Univ Sydney 2-loweralkylthioadenosines

Also Published As

Publication number Publication date
FR2209567B1 (sv) 1977-09-02
HU167859B (sv) 1975-12-25
DK134490B (da) 1976-11-15
GB1418120A (en) 1975-12-17
CH587864A5 (sv) 1977-05-13
DE2359536A1 (de) 1974-06-12
SE400295B (sv) 1978-03-20
FR2209567A1 (sv) 1974-07-05
CA1012534A (en) 1977-06-21
US3936439A (en) 1976-02-03
DE2359536C2 (de) 1984-08-02
DK134490C (sv) 1977-04-18

Similar Documents

Publication Publication Date Title
DK134490C (sv)
FR2171229B1 (sv)
FR2184547B3 (sv)
JPS528870B2 (sv)
CS177138B2 (sv)
JPS4964497U (sv)
CH572641A5 (sv)
CH560870A5 (sv)
CH570340A5 (sv)
CH570186A5 (sv)
CH570153A5 (sv)
CH569920A5 (sv)
CH569854A5 (sv)
CH569571A5 (sv)
CH569171A5 (sv)
CH567700A5 (sv)
CH567003A5 (sv)
CH566631A5 (sv)
CH566060A5 (sv)
CH565885A5 (sv)
CH570822A5 (sv)
CH572642A5 (sv)
CH562334A5 (sv)
CH561486A5 (sv)
NL7311585A (sv)

Legal Events

Date Code Title Description
BC A request for examination has been filed
BV The patent application has lapsed